KY-455 is a novel inhibitor of acyl-CoA:cholesterol acyltransferase ( ACAT ). KY-455 inhibita rabbit intestinal, hepatic, macrophage and adrenal ACAT with IC 50 values of 0.4, 0.9, 2.9 and 4.1 μmol/L, respectively.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Acyltransferase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.